Group 1 - The company announced the cancellation of 400,000 stock options that were granted but not exercised by 7 incentive recipients as part of the 2024 stock option incentive plan [2] - The decision was made during the 21st meeting of the third board of directors and the 18th meeting of the third supervisory board held on August 27, 2025 [2] - The company submitted the application for cancellation to the Shenzhen branch of China Securities Depository and Clearing Corporation Limited, which confirmed the cancellation on September 9, 2025 [2]

证券代码：002976 证券简称：瑞玛精密 公告编号：2025-076 苏州瑞玛精密工业集团股份有限公司 关于 2024 年股票期权激励计划部分股票期权 注销完成的公告 2025 年 8 月 27 日，苏州瑞玛精密工业集团股份有限公司（以下简称"公司"） 召开第三届董事会第二十一次会议与第三届监事会第十八次会议，审议通过了 《关于注销 2024 年股票期权激励计划部分股票期权的议案》，同意根据《上市 公司股权激励管理办法》、公司《2024 年股票期权激励计划（草案）》、公司 《2024 年股票期权激励计划实施考核管理办法》等相关规定以及公司 2024 年第 三次临时股东大会的授权，注销 7 名激励对象已获授但尚未行权的股票期权合计 40 万份，具体内容详见公司于 2025 年 8 月 29 日披露于巨潮资讯网的《关于注 销 2024 年股票期权激励计划部分股票期权的公告》（公告编号：2025-073）。 近日，公司向中国证券登记结算有限责任公司深圳分公司（以下简称"中登 公司"）提交了注销上述股票期权的申请，现经中登公司审核确认，上述股票期 权注销事项已于 2025 年 9 月 9 日办理完毕。 本次注销部分 ...

Group 1 - The core viewpoint of the news is that 瑞玛精密 has experienced a decline in stock price, with a cumulative drop of 9.4% over the past five days, closing at 23.91 yuan per share on September 4, with a total market capitalization of 2.897 billion yuan [1] - 瑞玛精密's main business involves the manufacturing of precision structural components and related precision mold manufacturing, with significant applications in the automotive and new energy vehicle sectors, accounting for 79.85% of its revenue [1] - The company was established on March 22, 2012, and went public on March 6, 2020, indicating a relatively recent entry into the public market [1] Group 2 - 大成中证360互联网+指数A (002236) has recently entered the top ten circulating shareholders of 瑞玛精密, holding 616,800 shares, which is 0.95% of the circulating shares [2] - The fund has incurred a floating loss of approximately 16.04 million yuan today, with a total floating loss of 152.97 million yuan during the five-day decline [2] - The fund has achieved a year-to-date return of 29.46% and a one-year return of 78.7%, ranking 1214 out of 4222 and 714 out of 3789 respectively in its category [2]

Group 1: 恒瑞医药 - Company received approval for clinical trials of HRS-7172 tablets, a new anti-tumor small molecule inhibitor [1] - Subsidiary received approval for SHR-A2009, an antibody-drug conjugate targeting HER3 [1] - Company was established in April 1997, focusing on drug research, production, and sales [1] Group 2: 康德莱 - Controlling shareholder plans to transfer 5% of shares to strategic investor at a price of 10.81 yuan per share, totaling 236 million yuan [1] - Post-transfer, controlling shareholder's stake will decrease from 39.58% to 34.58% [1] - Company was established in July 1998, specializing in medical devices [2] Group 3: 中钢洛耐 - Shareholder plans to reduce holdings by up to 1% of total shares due to fund exit needs [3] - Company was established in August 2006, focusing on high-end refractory materials [3] Group 4: 瑞玛精密 - Subsidiary completed acquisition of land in Mexico for production operations, covering 52,300 square meters at a price of 3.4064 million USD [4] - Company was established in March 2012, specializing in precision metal stamping and related products [4] Group 5: 鸿博股份 - Company confirmed normal operations despite stock price fluctuations exceeding 20% over three trading days [5] - Company was established in June 1999, focusing on lottery services and high-end packaging [6] Group 6: 东芯股份 - Company completed stock trading risk investigation and resumed trading [7] - Company was established in November 2014, specializing in storage chip design and sales [7] Group 7: 凯迪股份 - Company stated that its robot products are still in development and will not generate revenue in the short term [8] - Company was established in August 1992, focusing on linear drive systems [8] Group 8: 诺唯赞 - Major shareholder plans to reduce holdings by up to 3% due to funding needs [9] - Company was established in March 2012, focusing on functional proteins and organic materials [9] Group 9: 君实生物 - Company received approval for clinical trials of JT118 injection, a "two-in-one" recombinant protein vaccine for monkeypox [10] - Company was established in December 2012, focusing on new drug research and related services [10] Group 10: 赛力斯 - Company reported August sales of 45,818 vehicles, with a 19.57% increase in new energy vehicle sales [11] - Company was established in September 2012, focusing on automotive research and sales [11] Group 11: 燕东微 - Major shareholder plans to reduce holdings by up to 1% due to management needs [13] - Company was established in October 1987, focusing on semiconductor products and services [13] Group 12: 中百集团 - Company reported cumulative litigation and arbitration amounts of approximately 262 million yuan over the past 12 months [14] - Company was established in January 1990, focusing on retail business [14] Group 13: 金开新能 - Company received 939 million yuan in renewable energy subsidies, with a 341.67% increase year-on-year [15] - Company was established in March 1997, focusing on renewable energy development and operation [15] Group 14: *ST天茂 - Company plans to terminate stock listing and initiate cash option mechanism for shareholders [16] - Company was established in November 1993, focusing on various insurance services [16] Group 15: 宁德时代 - Company repurchased 8.69 million A-shares for a total of 2.131 billion yuan [17] - Company was established in December 2011, focusing on battery research and production [17] Group 16: 山西高速 - Controlling shareholder plans to increase holdings by 30 to 60 million yuan [18] - Company was established in February 1996, focusing on highway management [18] Group 17: 青岛银行 - Major shareholder plans to increase holdings by 233 to 291 million shares [19] - Company was established in November 1996, focusing on banking services [19] Group 18: 格力电器 - Major shareholder completed share increase of 46.38 million shares for 2.099 billion yuan [20] - Company was established in December 1989, focusing on air conditioning production and sales [20] Group 19: 中国石油 - Company plans to transfer 541 million A-shares to China Mobile Group to enhance strategic cooperation [21] - Company was established in November 1999, focusing on oil and gas exploration and production [21] Group 20: 镇洋发展 - Company announced a merger plan with Zhejiang Huhangyong Highway Co., with a share exchange ratio of 1:1.08 [22] - Company was established in December 2004, focusing on chemical products [22]

Group 1 - The company has approved the purchase of land in Apaseo El Grande, Guanajuato, Mexico, for a total price of $3.0855 million, equivalent to approximately 22.1817 million RMB [1][2] - The land will be used for production and operations in North America, with a purchase price of $59 per square meter for a total area of 52,297.39 square meters [1] - The transaction has been completed, and the subsidiary, Cheersson Queretaro Precision Metal Forming S. DE R.L.DE C.V., has paid the full transaction amount [2]

Group 1 - The company announced the completion of the land ownership transfer for a site located in Apaseo El Grande, Guanajuato, Mexico [1] - The total transaction price for the land was $3.4064 million [1] - The registered area of the land is 52,297.33 square meters [1]

证券代码：002976 证券简称：瑞玛精密 公告编号：2025-075 苏州瑞玛精密工业集团股份有限公司 关于在墨西哥购买土地事项进展暨交割完成的公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 一、交易事项概述 2025 年 1 月 17 日，苏州瑞玛精密工业集团股份有限公司(以下简称"公司") 召开第三届董事会第十四次会议，审议通过了《关于拟在墨西哥购买土地并签署< 土地购买意向协议书>的议案》，公司全资孙公司 Cheersson Queretaro Precision Metal Forming S. DE R.L.DE C.V.（以下简称"墨西哥瑞玛"）拟以 59 美元/平方 米的价格购买位于墨西哥瓜纳华托州 Apaseo El Grande 工业园 52,297.39 平方米土 地的永久所有权，作为公司在北美地区生产经营用地，交易总价为 308.55 万美元， 折合人民币约 2,218.17 万元（以中国人民银行于 2025 年 1 月 17 日公布的人民币 兑美元汇率中间价折算）。同日，墨西哥瑞玛与土地出让方 JLB PARQUES INDUS ...

Core Insights - The company reported a significant increase in revenue and net profit for the first half of 2025, with total revenue reaching 935 million yuan, a year-on-year increase of 23.22%, and net profit of 18.4 million yuan, up 164.57% [1] - The gross profit margin improved by 4.44% year-on-year, while the net profit margin saw a substantial increase of 131.28% [1] Financial Performance - Total revenue for the second quarter was 488 million yuan, reflecting a year-on-year growth of 9.42% [1] - The net profit for the second quarter was 5.49 million yuan, an increase of 16.55% year-on-year [1] - The gross profit margin for the reporting period was 22.01%, up 5.31% from the previous year, and the net profit margin was 1.43%, an increase of 131.28% [1] Cost Management - Total selling, administrative, and financial expenses amounted to 106 million yuan, accounting for 11.37% of revenue, which is a decrease of 13.02% year-on-year [1] - The company’s earnings per share (EPS) increased to 0.15 yuan, a rise of 150% compared to the previous year [1] Cash Flow and Debt Analysis - Cash and cash equivalents increased to 161 million yuan, a growth of 97.87% year-on-year [1] - The company’s interest-bearing liabilities rose to 624 million yuan, an increase of 22.36% [1] - The cash flow situation shows that cash and cash equivalents represent only 7.85% of total assets, and 24.43% of current liabilities [2] Historical Performance - The company has shown a median Return on Invested Capital (ROIC) of 14.57% since its listing, with the worst year being 2024, which had a ROIC of -0.62% [1] - The company has reported a total of four annual reports since its listing, with one year of losses, indicating the need for further investigation into potential special circumstances [1]

Core Viewpoint - The report discusses the cancellation of stock options for seven employees who have left the company, as part of the 2024 stock option incentive plan of Suzhou Ruima Precision Industrial Group Co., Ltd. This cancellation involves a total of 400,000 stock options that were granted but not exercised [7][8]. Summary by Sections Independent Financial Advisor Report - The independent financial advisor, Guojin Securities Co., Ltd., has been engaged to provide an opinion on the fairness and reasonableness of the stock option incentive plan for shareholders [2][3]. - The report is based on documents provided by Ruima Precision and includes an examination of the company's charter, board resolutions, and financial reports from the last three years [3]. Approval Procedures - The company has completed the necessary approval procedures for the stock option incentive plan, including resolutions passed by the board and supervisory committee [4][6]. - The first grant of stock options was publicly announced, and no objections were raised during the public notice period [5][6]. Cancellation of Stock Options - The cancellation of stock options is due to the departure of seven employees who no longer qualify as incentive recipients, resulting in the cancellation of 400,000 stock options [7][8]. - This cancellation is in accordance with the relevant regulations and will not affect the normal operation of the incentive plan or the company's financial status [8]. Conclusion - The independent financial advisor concludes that the cancellation of stock options has received the necessary approvals and complies with applicable laws and regulations [8].

Core Viewpoint - The legal opinion letter confirms that Suzhou Ruima Precision Industrial Group Co., Ltd. has legally canceled 400,000 stock options granted to seven departing incentive targets as part of its 2024 stock option incentive plan, in compliance with relevant laws and regulations [1][6][7]. Group 1: Approval and Authorization - The company has obtained necessary approvals and authorizations for the cancellation of stock options, including resolutions from the board of directors and supervisory board [3][4][6]. - Related directors have recused themselves from voting on the relevant proposals to ensure compliance with governance standards [4][5]. Group 2: Cancellation Details - The cancellation involves stock options that were granted but not exercised by seven departing incentive targets, as stipulated in the incentive plan [6][7]. - The cancellation aligns with the provisions of the Company Law, Securities Law, and the Management Measures for Incentive Plans [6][7]. Group 3: Information Disclosure - The company is required to disclose relevant decisions and documents related to the cancellation in accordance with the Management Measures and Listing Rules [6][7]. - The company will continue to fulfill its information disclosure obligations as the incentive plan progresses [7].